Ten years since the introduction of the first pneumococcal conjugate vaccine (PCV), leading global public health experts convened in Kuala Lumpur recently for the Asia Pneumococcal Disease (PD) Conference organized by Pfizer in collaboration with the Malaysian Pediatric Association.
The conference focused on Initial Impact Data on Invasive Pneumococcal Disease in Infants and Young Children following the Introduction of PCV-13 vaccine. Dr Bernard Fritzell, Vice-President, International Scientific & Clinical Affairs, Pfizer Vaccines was key speaker on the occasion.
